#Pfizer #HealthcareInnovation #DrugDevelopment #Obesity #CardiometabolicDisease #Biopharma #Incretin #Amylin To view or add a comment, sign in Ventyx CV Drug Slashes Inflammation Biomarker 78% in One Week Ventyx Biosciences' oral NLRP3 inhibitor VTX3232 delivered dramatic phase 2 results, reducing high-sensitivity C-reactive protein (hsCRP)a key biomarker for stroke and heart disease riskby 78% in just one week, with effects sustained through 12 weeks
Phentermine/topiramate ( Qsymia ): Topiramate is a once-daily medication used to treat seizures and prevent migraines
These statements describe ingredient-level structure/function mechanisms and have not been evaluated by the Food and Drug Administration
The glucagon component drives liver-fat reduction, and the real prize here is MASH, where the LIVERAGE program is still running
The strange thing is that you cant find many GLP-1 receptors in all these other organs where GLP-1 seems to work, said Drucker, whose earlier research showed how the GLP-1 gut hormone works at the molecular level and paved the way for several diabetes and weight-loss drugs, including Ozempic and Wegovy
That single structural change is the whole reason the compound exists as a distinct research object: it separates the matrikine signal from the copper carrier , and it reframes how the peptide partitions in membrane-containing assay systems